Safety and effectiveness of oxaliplatin-based chemotherapy regimens in adults 75 years and older with colorectal cancer

Clinical Colorectal Cancer

Volumn 12, Issue 1, 2013, Pages 62-69

  McCleary, Nadine Jackson ^a   Odejide, Oreofe ^a   Szymonifka, Jackie ^b   Ryan, David ^b   Hezel, Aram ^c   Meyerhardt, Jeffrey A ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Chemotherapy toxicity; Colorectal cancer; Comorbid medical conditions; Comparative effectiveness; Elderly; Oxaliplatin

Indexed keywords

BEVACIZUMAB; CAPECITABINE; FLUOROURACIL; FOLINIC ACID; OXALIPLATIN;

AGED; ARTICLE; BOLUS INJECTION; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CASE CONTROL STUDY; COHORT ANALYSIS; COLON METASTASIS; COLORECTAL CANCER; COMPARATIVE EFFECTIVENESS; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FAILURE TO THRIVE; FATIGUE; FEMALE; FOLLOW UP; GASTROINTESTINAL DISEASE; HEMATOLOGIC DISEASE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; NEUROPATHY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PAIN; RETROSPECTIVE STUDY; SKIN DISEASE; UNITED STATES;

EID: 84874724185     PISSN: 15330028     EISSN: 19380674     Source Type: Journal    
DOI: 10.1016/j.clcc.2012.09.001     Document Type: Article

References (24)

1. D. Schrag, L.D. Cramer, P.B. Bach Age and adjuvant chemotherapy use after surgery for stage III colon cancer J Natl Cancer Inst 93 2001 850 857
2. Sugrue MM, KM, Hainsworth J, et al. Safety and effectiveness of bevacizumab plus chemotherapy in elderly patients with mCRC: results from the BRiTE registry. Presented at 2007 Gastrointestinal Cancers Symposium, January 19-21, 2007; Orlando, FL. Abstract 345. Available at: www.asco.org. Accessed October 1, 2012.
3. D.G. Haller, J. Tabernero, J. Maroun Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer J Clin Oncol 29 2011 1465 1471
4. L.F. Hutchins, J.M. Unger, J.J. Crowley Underrepresentation of patients 65 years of age or older in cancer-treatment trials N Engl J Med 341 1999 2061 2067
5. J.H. Stewart, A.G. Bertoni, J.L. Staten Participation in surgical oncology clinical trials: gender-, race/ethnicity-, and age-based disparities Ann Surg Oncol 14 2007 3328 3334
6. C.A. Townsley, R. Selby, L.L. Siu Systematic review of barriers to the recruitment of older patients with cancer onto clinical trials J Clin Oncol 23 2005 3112 3124
7. A. Yazdanyar, A.B. Newman The burden of cardiovascular disease in the elderly: morbidity, mortality, and costs Clin Geriatr Med 25 2009 563 577 vii
8. G. Yothers, M.J. O'Connell, C.J. Allegra Oxaliplatin as adjuvant therapy for colon cancer: updated results of NSABP C-07 trial, including survival and subset analyses J Clin Oncol 29 2011 3768 3774
9. A. Tournigand, Teixeira Bachet Multicenter International Study of Oxaliplatin/5-Fluorouracil/Leucovorin in the Adjuvant Treatment of Colon Cancer (MOSAIC) investigators and GERCOR FOLFOX4 as adjuvant therapy in elderly patients with colon cancer: subgroup analysis of the MOSAIC trial J Clin Oncol 28 suppl 2010 abstract 3522 www.asco.org Accessed October 1, 2012
10. J.G. Ford, M.W. Howerton, G.Y. Lai Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review Cancer 112 2008 228 242
11. R.M. Goldberg, I. Tabah-Fisch, H. Bleiberg Pooled analysis of safety and efficacy of oxaliplatin plus fluorouracil/leucovorin administered bimonthly in elderly patients with colorectal cancer J Clin Oncol 24 2006 4085 4091
12. Surveillance Epidemiology and End Results. (SEER) http://seer.cancer.gov/ Accessed: October 1, 2012
13. G. Yothers, L. O'Connelll, J.P. Colangelo 5-FU and leucovorin with or without oxaliplatin for adjuvant treatment of stage II and III colon cancer: long-term follow-up of NSABP C-07 with survival analysis 2010 Gastrointestinal Cancers Symposium; January 22-24, 2010; Orlando, FL www.asco.org Accessed: October 1, 2012
14. A. Hurria, S.G. Mohile Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study T.K. J Clin Oncol 29 2011 3457 3464
15. N.A. Jackson McCleary, J. Meyerhardt, E. Green Impact of older age on the efficacy of newer adjuvant therapies in >12,500 patients (pts) with stage II/III colon cancer: findings from the ACCENT database J Clin Oncol 27 suppl 2009 abstract 4010
16. D.G. Haller, J. Cassidy, J. Tabernero Efficacy findings from a randomized phase III trial of capecitabine plus oxaliplatin versus bolus 5-FU/LV in stage III colon cancer (NO16968): no impact of age on disease-free survival (DFS) 2010 Gastrointestinal Cancers Symposium; January 22-24, 2010; Orlando, FL. Abstract 284 www.asco.org Accessed: October 1, 2012
17. H.K. Sanoff, W.R. Carpenter, Stümer The effect of adjuvant chemotherapy on survival of patients with stage III colon cancer diagnosed after age 75 years J Clin Oncol 30 2012 2624 2634
18. T. McKibbin, C.R. Frei, R.E. Greene Disparities in the use of chemotherapy and monoclonal antibody therapy for elderly advanced colorectal cancer patients in the community oncology setting Oncologist 13 2008 876 885
19. A. Hurria, S. Gupta, M. Zauderer Developing a cancer-specific geriatric assessment: a feasibility study Cancer 104 2005 1998 2005
20. A. Hurria, C.T. Cirrincione, H.B. Muss Implementing a geriatric assessment in cooperative group clinical cancer trials: CALGB 360401 J Clin Oncol 29 2011 1290 1296
21. U. Wedding, D. Ködding, L. Pientka Physicians' judgement and comprehensive geriatric assessment (CGA) select different patients as fit for chemotherapy Crit Rev Oncol Hematol 64 2007 1 9
22. M. Extermann, A. Hurria Comprehensive geriatric assessment for older patients with cancer J Clin Oncol 25 2007 1824 1831
23. A. Hurria, S.M. Lichtman, J. Gardes Identifying vulnerable older adults with cancer: integrating geriatric assessment into oncology practice J Am Geriatr Soc 55 2007 1604 1608
24. H.K. Sanoff, W.R. Carpenter, T. Stürmer Effect of adjuvant chemotherapy on survival of patients with stage III colon cancer diagnosed after age 75 years J Clin Oncol 30 2012 2624 2634